FCGR1A and Sepsis: For prognostic evaluation purposes, sepsis patients were reclassified according to NICU mortality into nonsurvivor sepsis (n = 30) and survivors sepsis patients (n = 61), the comparison was conducted between both categories, and the results showed significant differences between both groups regarding CD64% (P < 0.001), platelet count (P < 0.001), hs-CRP (P = 0.018), and CD64 MFI (P = 0.003).